EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The role of long noncoding RNA DGCR5 in cancers: Focus on molecular targets

Sulieman I S Al-Hawary iD, Paul Rodrigues, Harun Bangali, Zahraa F Hassan, Ahmed Elawady

Cell Biochemistry and Function · 2024

DOI: 10.1002/cbf.3949 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cell Biochemistry and Function, 2024. Verfasst von Sulieman I S Al-Hawary und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Al al-Bayt University, Mafraq, Jordan. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 161 Literaturangaben. Gefördert von: King Khalid University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Long noncoding RNAs (lncRNAs) are major components of cellular transcripts that are emerging as important players in various biological pathways. Due to their specific expression and functional diversity in a variety of cancers, lncRNAs have promising applications in cancer diagnosis, prognosis, and therapy. Studies have shown that lncRNA DiGeorge syndrome critical region gene 5 (DGCR5) with high specificity and accuracy has the potential to become biomarkers in cancers. LncRNA DGCR5 can be noninvasively extracted from body fluids, tissues, and cells, and can be used as independent or auxiliary biomarkers to improve the accuracy of diagnosis or prognosis. Now, the underlying mechanisms of lncRNAs such as DGCR5 were explored as therapeutic targets, which have been investigated in clinical trials of several cancers. The DGCR5 lacks an appropriate animal model, which is necessary to gain greater knowledge of their functions. While some studies on the uses of DGCR5 have been carried out, the small sample size makes them unreliable. In this review, we presented a compilation of recent publications addressing the potential of lncRNA DGCR5 that could be considered as biomarkers or therapeutic targets, with the hopes of providing promised implications for future cancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Long NoncodingNeoplasmsAnimalsCell Line, TumorBiomarkersGene Expression Regulation, NeoplasticBiomarkers, Tumor

Stichwörter der Autor:innen

DGCR5cancerlncRNAsignalingtherapy

Substanzen

RNA, Long NoncodingBiomarkersBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Medicine, Al al-Bayt University, Mafraq, Jordan.
  • Department of Computer Engineering, College of Computer Science, King Khalid University, Al-Faraa, Saudi Arabia.
  • College of Dentistry, Al-Ayen University, Thi-Qar, Iraq.
  • College of Technical Engineering, The Islamic University, Najaf, Iraq.
  • College of Technical Engineering, The Islamic University of Al Diwaniyah, Al Diwaniyah, Iraq.
  • College of Technical Engineering, The Islamic University of Babylon, Babylon, Iraq.

ORCID-Profile: Sulieman I S Al-Hawary

Förderung

  • King Khalid University

Zitieren

APA

Al-Hawary, S. I. S., Rodrigues, P., Bangali, H., Hassan, Z. F., & Elawady, A. (2024). The role of long noncoding RNA DGCR5 in cancers: Focus on molecular targets. Cell Biochemistry and Function. https://doi.org/10.1002/cbf.3949

Vancouver

Al-Hawary SIS, Rodrigues P, Bangali H, Hassan ZF, Elawady A. The role of long noncoding RNA DGCR5 in cancers: Focus on molecular targets. Cell Biochemistry and Function. 2024. doi:10.1002/cbf.3949

BibTeX
@article{AlHawary2024,
  author = {Al-Hawary, Sulieman I S and Rodrigues, Paul and Bangali, Harun and Hassan, Zahraa F and Elawady, Ahmed},
  title = {The role of long noncoding RNA DGCR5 in cancers: Focus on molecular targets},
  journal = {Cell Biochemistry and Function},
  year = {2024},
  doi = {10.1002/cbf.3949}
}
Kostenlos starten →